DE602006003320D1 - Herstellung eines substituierten chinoxalins von hoher reinheit - Google Patents
Herstellung eines substituierten chinoxalins von hoher reinheitInfo
- Publication number
- DE602006003320D1 DE602006003320D1 DE602006003320T DE602006003320T DE602006003320D1 DE 602006003320 D1 DE602006003320 D1 DE 602006003320D1 DE 602006003320 T DE602006003320 T DE 602006003320T DE 602006003320 T DE602006003320 T DE 602006003320T DE 602006003320 D1 DE602006003320 D1 DE 602006003320D1
- Authority
- DE
- Germany
- Prior art keywords
- preparation
- substituted
- chinoxaline
- high purity
- cyclization
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65629605P | 2005-02-24 | 2005-02-24 | |
PCT/IB2006/000351 WO2006090236A1 (en) | 2005-02-24 | 2006-02-21 | Preparation of high purity substituted quinoxaline |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602006003320D1 true DE602006003320D1 (de) | 2008-12-04 |
Family
ID=36405938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602006003320T Expired - Fee Related DE602006003320D1 (de) | 2005-02-24 | 2006-02-21 | Herstellung eines substituierten chinoxalins von hoher reinheit |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080275051A1 (de) |
EP (1) | EP1866308B1 (de) |
JP (1) | JP2008531540A (de) |
KR (1) | KR20070098942A (de) |
CN (1) | CN101128462A (de) |
AT (1) | ATE411994T1 (de) |
AU (1) | AU2006217616A1 (de) |
BR (1) | BRPI0607838A2 (de) |
CA (1) | CA2598533A1 (de) |
DE (1) | DE602006003320D1 (de) |
ES (1) | ES2313625T3 (de) |
IL (1) | IL185013A0 (de) |
MX (1) | MX2007010375A (de) |
RU (1) | RU2007131535A (de) |
WO (1) | WO2006090236A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090086071A (ko) | 2006-11-09 | 2009-08-10 | 화이자 프로덕츠 인코포레이티드 | 니코틴 중간체의 다형체 |
WO2009065872A2 (en) * | 2007-11-20 | 2009-05-28 | Medichem, S.A. | Improved processes for the synthesis of varenicline l-tartrate |
WO2009143347A2 (en) | 2008-05-22 | 2009-11-26 | Teva Pharmaceutical Industries Ltd. | Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate |
WO2009155403A2 (en) * | 2008-06-19 | 2009-12-23 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of varenicline and intermediates thereof |
US20100010221A1 (en) * | 2008-07-10 | 2010-01-14 | Revital Lifshitz-Liron | Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt |
RU2012102052A (ru) | 2009-06-22 | 2013-11-20 | Тева Фармасьютикал Индастриз Лтд. | Твердые формы солей варениклина и способы их получения |
US20120277433A1 (en) * | 2009-12-29 | 2012-11-01 | Mahendranath Rao Narasimha Rao | Process for the preparation of substituted quinoxalines |
WO2011110954A1 (en) * | 2010-03-09 | 2011-09-15 | Actavis Group Ptc Ehf | Highly pure varenicline or a pharmaceutically acceptable salt thereof substantially free of methylvarenicline impurity |
US20120004239A1 (en) * | 2010-06-11 | 2012-01-05 | Medichem, S.A. | Process for Preparing Quinoxaline Derivatives |
CN113956255A (zh) * | 2020-07-20 | 2022-01-21 | 威智医药有限公司 | 一种伐尼克兰中间体、伐尼克兰及其盐的制备方法 |
WO2022035434A1 (en) | 2020-08-14 | 2022-02-17 | Almatica Pharma Llc | Cocrystal of varenicline and oxalic acid, pharmaceutical composition thereof, and methods of use thereof |
WO2022222019A1 (en) * | 2021-04-20 | 2022-10-27 | Suzhou Fude Zhaofeng Biochemical Technology Co., Ltd | Total synthesis of varenicline |
CN114349701B (zh) * | 2022-01-07 | 2024-04-05 | 江苏豪森药业集团有限公司 | 一种酒石酸伐尼克兰中间体的制备方法 |
US11602537B2 (en) | 2022-03-11 | 2023-03-14 | Par Pharmaceutical, Inc. | Varenicline compound and process of manufacture thereof |
EP4241775A1 (de) | 2022-03-11 | 2023-09-13 | Par Pharmaceutical, Inc. | Tablette mit vareniclin und verfahren zur herstellung davon |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK286886B6 (sk) * | 1997-12-31 | 2009-07-06 | Pfizer Products Inc. | Azapolycyklické zlúčeniny s anelovanou arylskupinou, ich použitie, farmaceutické kompozície na ich báze a medziprodukty |
US6605610B1 (en) * | 1997-12-31 | 2003-08-12 | Pfizer Inc | Aryl fused azapolycyclic compounds |
SK287170B6 (sk) * | 2001-05-14 | 2010-02-08 | Pfizer Products Inc. | Tartrátová soľ 5,8,14-triazatetracyklo-[10.3.1.02,11.04,9]- hexadeka-2(11),3,5,7,9-pentaénu, jej použitie a farmaceutická kompozícia s jej obsahom |
JP2006526607A (ja) * | 2003-06-04 | 2006-11-24 | ファイザー・プロダクツ・インク | 2,3−ジヒドロキシ−1,4−ヂオキサンを用いたジアニリンからの置換キノキサリンの製造方法 |
-
2006
- 2006-02-21 CA CA002598533A patent/CA2598533A1/en not_active Abandoned
- 2006-02-21 WO PCT/IB2006/000351 patent/WO2006090236A1/en active Application Filing
- 2006-02-21 RU RU2007131535/04A patent/RU2007131535A/ru not_active Application Discontinuation
- 2006-02-21 BR BRPI0607838-9A patent/BRPI0607838A2/pt not_active IP Right Cessation
- 2006-02-21 AU AU2006217616A patent/AU2006217616A1/en not_active Abandoned
- 2006-02-21 MX MX2007010375A patent/MX2007010375A/es not_active Application Discontinuation
- 2006-02-21 AT AT06710423T patent/ATE411994T1/de not_active IP Right Cessation
- 2006-02-21 JP JP2007556673A patent/JP2008531540A/ja active Pending
- 2006-02-21 US US11/722,817 patent/US20080275051A1/en not_active Abandoned
- 2006-02-21 DE DE602006003320T patent/DE602006003320D1/de not_active Expired - Fee Related
- 2006-02-21 CN CNA2006800060133A patent/CN101128462A/zh active Pending
- 2006-02-21 KR KR1020077019287A patent/KR20070098942A/ko not_active Application Discontinuation
- 2006-02-21 ES ES06710423T patent/ES2313625T3/es active Active
- 2006-02-21 EP EP06710423A patent/EP1866308B1/de not_active Not-in-force
-
2007
- 2007-08-02 IL IL185013A patent/IL185013A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2598533A1 (en) | 2006-08-31 |
RU2007131535A (ru) | 2009-03-27 |
ES2313625T3 (es) | 2009-03-01 |
MX2007010375A (es) | 2007-09-25 |
JP2008531540A (ja) | 2008-08-14 |
EP1866308A1 (de) | 2007-12-19 |
IL185013A0 (en) | 2007-12-03 |
ATE411994T1 (de) | 2008-11-15 |
CN101128462A (zh) | 2008-02-20 |
BRPI0607838A2 (pt) | 2009-06-13 |
US20080275051A1 (en) | 2008-11-06 |
EP1866308B1 (de) | 2008-10-22 |
WO2006090236A1 (en) | 2006-08-31 |
KR20070098942A (ko) | 2007-10-05 |
AU2006217616A1 (en) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE411994T1 (de) | Herstellung eines substituierten chinoxalins von hoher reinheit | |
ES2338590T3 (es) | Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos. | |
MX2007014172A (es) | Procedimiento para la produccion de 4-bifenililacetidina-2-onas fenolicos. | |
MX339476B (es) | Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso. | |
TN2011000279A1 (en) | Novel pyrazole -4-n-alkoxycarboxamides as microbiocides | |
EA201170132A1 (ru) | 5-гетероциклилалкил-3-гидрокси-2-фенилциклопент-2-еноны в качестве гербицидов | |
CL2011000936A1 (es) | Proceso de preparacion de compuestos derivados de l-alanina protegidos, utiles como intermediarios de la sintesis de compuestos moduladores opioides mu/delta. | |
EA201101099A1 (ru) | Гербициды, полученные из циклопентадиона | |
EA201070804A1 (ru) | (аза)индольное производное, замещенное по положению 5, содержащая его фармацевтическая композиция, промежуточные соединения и способ их получения | |
UA106880C2 (uk) | Нові гербіциди | |
TN2010000045A1 (en) | Novel herbicides | |
EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
TW200716564A (en) | Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents | |
NO20074047L (no) | Ny fremgangsmate for fremstilling av substituerte indoler | |
EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
CY1110688T1 (el) | Διεργασια για την παρασκευη καρβεδιλολης και εναντιομερων αυτης | |
HRP20051005A2 (en) | Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives | |
ATE503767T1 (de) | Herstellung eines von willenbrand faktor- präparates mit hoher spezifischer aktivität | |
NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
DK1926732T3 (da) | Fremgangsmåde til fremstillingen af carbapenemforbindelser | |
DE602006005349D1 (de) | Verfahren zur herstellung von hydrazon-derivaten | |
UY29879A1 (es) | Derivados de 6-heteroarilpiridoindolona, su preparación y su aplicación en terapéutica | |
MX2007013872A (es) | Procedimiento para la produccion de 4-bifenililazetidina-2-onas. | |
NO20065157L (no) | Biotransformasjon av colchicinoidforbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |